ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Mergers & Acquisitions

India’s Ipca acquires rival Ramdev Chemical

by Michael McCoy
May 4, 2019 | APPEARED IN VOLUME 97, ISSUE 18

 

The Indian pharmaceutical-chemical maker Ipca Laboratories has acquired Ramdev Chemical for about $16 million. Like Ipca, Ramdev produces fine chemicals, drug intermediates, and active pharmaceutical ingredients (APIs). It has annual sales of about $11 million and 170 employees. Ipca acquired the British pharmaceutical chemistry firm Onyx Scientific in 2011 and the North Carolina API maker Pisgah Labs last year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment